J. Crook

发表

Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy.

G. Pond, D. Taussky, I. Yeung, 2006, International journal of radiation oncology, biology, physics.

The effect of seed orientation deviations on the quality of 125I prostate implants.

J J Jezioranski, J Crook, I. Yeung, 2001, Physics in medicine and biology.

Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion.

Ivan Yeung, Daniel Taussky, Gregory Pond, 2004, International journal of radiation oncology, biology, physics.

Inter-institutional variation of implant activity for permanent prostate brachytherapy.

J. Sylvester, W. Butler, G. Merrick, 2008, Brachytherapy.

Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.

Ivan Yeung, Jette Borg, I. Yeung, 2009, International journal of radiation oncology, biology, physics.

Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.

L. Potters, M. Zelefsky, R. Stock, 2005, Brachytherapy.

Patient-assessed late toxicity rates and principal component analysis after image-guided radiation therapy for prostate cancer.

G. Lockwood, T. Rosewall, C. Catton, 2007, International journal of radiation oncology, biology, physics.

Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning.

Deidre Batchelar, Cynthia Araujo, Matt Schmid, 2014, Brachytherapy.

Prostate motion during standard radiotherapy as assessed by fiducial markers.

J. Crook, Y. Raymond, D. Salhani, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Respiratory-induced prostate motion: quantification and characterization.

J Szanto, J. Crook, W. Kendal, 2000, International journal of radiation oncology, biology, physics.

A prospective comparison of three systems of patient immobilization for prostate radiotherapy.

J Szanto, L Gerig, J Crook, 2000, International journal of radiation oncology, biology, physics.

Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma

G. Perry, J. Crook, B. Esche, 1997, Cancer.

Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.

W. J. Morris, M. Keyes, J. Crook, 2015, Brachytherapy.

Report on the Clinical Outcomes of Permanent Breast Seed Implant for Early-Stage Breast Cancers.

Jean-Philippe Pignol, Claire McCann, J. Crook, 2015, International journal of radiation oncology, biology, physics.

Characterization and registration of 3D ultrasound for use in permanent breast seed implant brachytherapy treatment planning.

A. Fenster, L. Gardi, J. Crook, 2020, Brachytherapy.

Seroma Visualization and Implant Accuracy in Permanent Breast Seed Implant Brachytherapy.

J. Crook, M. Hilts, A. Tétreault-Laflamme, 2019, Practical radiation oncology.

Permanent breast seed implant for partial breast radiotherapy after partial mastectomy for favorable breast cancer: Technique, results, and applications to various seroma presentations.

M. Milette, J. Crook, M. Hilts, 2019, Brachytherapy.

A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).

D. Beyer, C. Catton, H. Sandler, 2017, International journal of radiation oncology, biology, physics.

The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer

J. Crook, S. Tisseverasinghe, 2018, Translational andrology and urology.

Prognostic factors for newly diagnosed prostate cancer and their role in treatment selection.

J. Crook, A. Ots, 2013, Seminars in radiation oncology.

In regard to "Dose escalation in the radiation therapy of prostate cancer" (Int J Radiat Oncol Biol Phys 2011;80:1289-1291).

J. Crook, D. Bowes, 2012, International journal of radiation oncology, biology, physics.

A surrogate urethra for real-time planning of high-dose-rate prostate brachytherapy.

J. Crook, M. Hilts, A. Tétreault-Laflamme, 2019, Brachytherapy.

The Impact of MRI Training on Improvement of CT Based Post Implant Dosimetry: A Six Physician Study

W. R. Lee, M. Zelefsky, P. McLaughlin, 2005 .

Establishing a simulation-based education program for radiation oncology learners in permanent seed implant brachytherapy: Building validation evidence.

J. Crook, E. Watt, M. Roumeliotis, 2019, Brachytherapy.

Implications of CT imaging for postplan quality assessment in prostate brachytherapy.

J. Crook, R. Halperin, C. Araujo, 2010, Brachytherapy.

Percent free prostate-specific antigen after radiotherapy for prostate cancer.

J. Crook, P. Bunting, 1998, Urology.

Deformable image registration for defining the postimplant seroma in permanent breast seed implant brachytherapy.

J. Crook, M. Hilts, D. Batchelar, 2015, Brachytherapy.

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

J. Crook, B. Esche, S. Robertson, 1993, International journal of radiation oncology, biology, physics.

Intermittent androgen suppression in the management of prostate cancer.

J. Crook, R. Segal, E. Szumacher, 1999, Urology.

Society of Urologic Oncology position statement: Redefining the management of hormone‐refractory prostate carcinoma

Sam S. Chang, C. Higano, M. Benson, 2005, Cancer.

Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation.

J. Crook, W. Walop, J. Mazeron, 1990, International journal of radiation oncology, biology, physics.

Quality of Life, Morbidity, and Mortality Results of a Prospective Phase II Study of Intermittent Androgen Suppression for Men with Evidence of Prostate-Specific Antigen Relapse After Radiation Therapy for Locally Advanced Prostate Cancer

N. Bruchovsky, J. Crook, L. Klotz, 2008 .

Salvage Local Treatments After Focal Therapy for Prostate Cancer.

M. Emberton, J. Crook, L. Pisters, 2019, European urology oncology.

Peer-based credentialing for brachytherapy: Application in permanent seed implant.

J. Crook, S. Kry, E. Watt, 2020, Brachytherapy.

Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome.

L. Eapen, G. Perry, S. Dahrouge, 2007, International journal of radiation oncology, biology, physics.

Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.

C. Catton, É. Vigneault, J. Crook, 2015, International journal of radiation oncology, biology, physics.

Current concepts in penile cancer.

J. Crook, P. Spiess, M. Biagioli, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Impact of intraoperative MRI/TRUS fusion on dosimetric parameters in cT3a prostate cancer patients treated with high-dose-rate real-time brachytherapy

J. Crook, P. Bilbao, P. Mínguez, 2014, Journal of contemporary brachytherapy.

Pretreatment Multiparametric Magnetic Resonance Imaging Findings Are More Accurate Independent Predictors of Outcome Than Clinical Variables in Localized Prostate Cancer.

J. Crook, G. Villeirs, J. Pijoan, 2017, International journal of radiation oncology, biology, physics.

Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer.

A. D'Amico, P. Kantoff, Ming-Hui Chen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial.

J. Crook, H. Pai, P. Truong, 2010, International journal of radiation oncology, biology, physics.

External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer.

C. Catton, D. Taussky, J. Crook, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Establishing high-quality prostate brachytherapy using a phantom simulator training program.

D. Kuban, L. Potters, M. Keyes, 2014, International journal of radiation oncology, biology, physics.

Defining a magnetic resonance scan sequence for permanent seed prostate brachytherapy postimplant assessment.

J. Crook, Brent Parker, R. Rajapakshe, 2013, Brachytherapy.

UltrasoundeCT fusion compared with MReCT fusion for postimplant dosimetry in permanent prostate brachytherapy

J. Crook, D. Bowes, D. Batchelar, 2012 .

Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer

F. O'Malley, J. Crook, S. Panchal, 2009, Nature Reviews Clinical Oncology.

Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.

L. Eapen, J. Crook, C. Danjoux, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Advanced Image Guidance Allows Margin Reduction in Radiation Therapy of Prostate Cancer

K. Brock, C. Ménard, D. Jaffray, 2008 .

Primary and adjuvant radiation therapy in the management of penile cancer

J. Crook, O. Algan, 2014 .

Surgery versus implant for early prostate cancer: what is equivalence?

J. Crook, 2007, Cancer journal.

Canadian consensus definition of prostate cancer risk stratification

W. J. Morris, M. Keyes, É. Vigneault, 2013 .

The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers.

J. Trachtenberg, R. Bristow, F. Jalali, 2011, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Radiation therapy for cancer of the penis.

J. Crook, 2010, The Urologic clinics of North America.

Development of ProCaRS Clinical Nomograms for Biochemical Failure-free Survival Following Either Low-Dose Rate Brachytherapy or Conventionally Fractionated External Beam Radiation Therapy for Localized Prostate Cancer

C. Catton, J. Crook, G. Rodrigues, 2015, Cureus.

The effect of radiation on semen quality and fertility in men treated with brachytherapy for early stage prostate cancer.

J. Crook, K. Hersey, K. Jarvi, 2012, The Journal of urology.

Androgen deprivation therapy: minimizing exposure and mitigating side effects.

J. Crook, M. Gaztañaga, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Long‐term side‐effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study

G. Perry, S. Dahrouge, J. Crook, 2005, BJU international.

Locally Advanced Prostate Cancer Biochemical Recurrence after Radiotherapy: Use of Cyclic Androgen Withdrawal Therapy

J. Crook, 2008 .

Androgen suppression therapy, in combination with radiotherapy prolongs overall survival in men with clinically localised prostate cancer.

J. Crook, 2005, Cancer treatment reviews.

Neonatal circumcision and invasive squamous cell carcinoma of the penis: a report of 3 cases and a review of the literature.

J. Crook, E. Saibishkumar, J. Sweet, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

The efficacy of hyperbaric oxygen therapy in the treatment of medically refractory soft tissue necrosis after penile brachytherapy.

J. Crook, J. Jezioranski, E. Saibishkumar, 2011, Brachytherapy.

PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.

G. Lockwood, I. Yeung, M. Mclean, 2007, International journal of radiation oncology, biology, physics.

The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer

J. Crook, J. Rose, 2015, Therapeutic advances in urology.

Significant toxicities after single fraction HBI include ‘ acute radiation syndrome ’ characterized by severe nausea and vomiting , fever , tachycardia and hypotension

J. Crook, J. Rose, 2015 .

Radiation therapy and radio-nuclides for palliation of bone pain.

J. Crook, 2006, The Urologic clinics of North America.

Serum prostate-specific antigen profile following radiotherapy for prostate cancer: implications for patterns of failure and definition of cure.

G. Perry, J. Crook, B. Esche, 1998, Urology.

Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.

J. Crook, C. Araujo, S. Tisseverasinghe, 2021, Brachytherapy.

Hypofractionated intensity modulated radiation therapy for prostate cancer

R. Bristow, C. Catton, P. Warde, 2002 .

What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes

J. Crook, P. Spiess, R. Campi, 2022, European urology open science.

Prediction of disease progression indicators in prostate cancer patients receiving HDR-brachytherapy using Raman spectroscopy and semi-supervised learning: a pilot study

Jeffrey L. Andrews, J. Crook, A. Jirasek, 2022, Scientific Reports.

Malignant Inguinal Adenopathy: Considerations for the Radiation Oncologist

J. Crook, M. Korzeniowski, 2018 .

Contemporary role of radiotherapy in the management of penile cancer

J. Crook, M. Korzeniowski, 2017, Translational andrology and urology.

Contemporary Role of Radiotherapy in the Management of Primary Penile Tumors and Metastatic Disease.

J. Crook, 2016, The Urologic clinics of North America.

The Role of Radiotherapy in Penile Cancer

J. Crook, 2016 .

Organ preserving radiation strategies for penile cancer.

J. Crook, 2020, Urologic oncology.

Penile cancer update 2011: a case-based approach.

J. Crook, C. Pettaway, L. Pagliaro, 2012, Urologic oncology.

Proliferative cell nuclear antigen in postradiotherapy prostate biopsies.

J. Crook, B. Esche, S. Robertson, 1994, International journal of radiation oncology, biology, physics.

The Role of Intermittent Androgen Deprivation Therapy in the Management of Biochemically Recurrent or Metastatic Prostate Cancer

J. Crook, J. Jaswal, 2015, Current Urology Reports.

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer

Nicholas Bruchovsky, W James Morris, M. Gleave, 2006, Cancer.

Locally advanced prostate cancer—biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate‐specific antigen recurrence after radiotherapy

Nicholas Bruchovsky, N. Bruchovsky, J. Crook, 2007, Cancer.

Locally advanced prostate cancer--biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy.

Nicholas Bruchovsky, N. Bruchovsky, J. Crook, 2007 .

Is a Diagnosis of Inflammatory Bowel Disease

C. Catton, J. Crook, P. Chung, 2004 .

Feasibility study of defining planning target volume using surgical margins in permanent breast seed implant brachytherapy.

J. Crook, M. Hilts, D. Batchelar, 2022, Brachytherapy.

Biochemical Response is More Critical than Total Duration of Neo-adjuvant Hormone Therapy (NAHT) Prior to Radiotherapy for Localized Prostate Cancer: Analysis of the 3 vs 8 Month Data

J. Crook, M. Lesperance, A. Alexander, 2008 .

Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer

K. Ding, J. Crook, L. Klotz, 2021, The Journal of urology.

The effect of voxel size on the accuracy of dose-volume histograms of prostate 125I seed implants.

I. Yeung, J. Crook, J. Corbett, 2002, Medical physics.

Long-term urinary sequelae following 125iodine prostate brachytherapy.

G. Pond, J. Crook, N. Fleshner, 2008, The Journal of urology.

The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.

D. Dearnaley, K. Ding, E. Horwitz, 2015, European urology.

After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis.

W. J. Morris, I. Spadinger, M. Keyes, 2022, Brachytherapy.

Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma

D. Beyer, C. Catton, H. Sandler, 2016 .

A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013).

P. Schellhammer, F. Saad, J. Chin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013.

D. Dearnaley, K. Ding, E. Horwitz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermittent androgen suppression for rising PSA level after radiotherapy.

Fred Saad, Emma Hall, Graeme Duncan, 2012, The New England journal of medicine.

Quality of life, morbidity, and mortality results of a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen relapse after radiation therapy for locally advanced prostate cancer.

N. Bruchovsky, J. Crook, L. Klotz, 2008, Clinical genitourinary cancer.

Intermittent androgen suppression for prostate cancer: Canadian Prospective Trial and related observations.

M. Gleave, N. Bruchovsky, J. Crook, 2000, Molecular urology.

Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

J. Crook, A. Eisen, N. Fleshner, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.

J. Crook, S. Radomski, Oren M Shemtov, 2004, The Canadian journal of urology.

Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curiethérapie.

J. Crook, J. Mazeron, F. Brunin, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Interstitial iridium 192 for cutaneous carcinoma of the external nose.

J. Crook, J. Mazeron, G. Marinello, 1990, International journal of radiation oncology, biology, physics.

The role of radiotherapy in the management of penile cancer.

J. Crook, 2015, Current problems in cancer.

Penile brachytherapy: technical aspects and postimplant issues.

J. Cygler, J. Crook, J. Jezioranski, 2010, Brachytherapy.

Landmarks in prostate cancer

F. Saad, N. Lawrentschuk, J. Crook, 2018, Nature Reviews Urology.

American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy.

Wayne M Butler, Louis Potters, Anthony L Zietman, 2012, Brachytherapy.

Pre-treatment risk stratification of prostate cancer patients: A critical review.

P. Warde, M. Brundage, J. Crook, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer.

M. Johnston, J. Crook, L. Klotz, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer.

Pamela Catton, Charles Catton, C. Parker, 2004, International Journal of Radiation Oncology, Biology, Physics.

The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.

C. Catton, P. Warde, M. Brundage, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effectiveness of educational intervention on the congruence of prostate and rectal contouring as compared with a gold standard in three-dimensional radiotherapy for prostate.

Adam Dubrowski, Nicole Harnett, Ruth Barker, 2010, International journal of radiation oncology, biology, physics.

American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.

C. Haie-meder, J. Crook, M. Rivard, 2013, Brachytherapy.

Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT.

D. Dearnaley, K. Ding, E. Horwitz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management.

C. Catton, P. Warde, J. Crook, 2003, The Urologic clinics of North America.

Should intermittent androgen deprivation be used in routine clinical practice?

J. Crook, M. Hussain, Juanita Crook, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.

A. D'Amico, P. Kantoff, Ming-Hui Chen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermediate-risk Prostate Cancer: Stratification and Management.

A. D'Amico, M. Cooperberg, R. Montironi, 2020, European urology oncology.

A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy.

R. Bristow, G. Lockwood, A. Nichol, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.

L. Potters, T. D. de Reijke, J. Kleijnen, 2015, European journal of cancer.

Permanent seed brachytherapy for locally recurrent prostate cancer after radical prostatectomy: a case report and review of the literature.

J. Crook, M. Gaztañaga, 2013, Brachytherapy.

Interpreting a rising prostate‐specific antigen after brachytherapy for prostate cancer

J. Crook, M. Gaztañaga, 2013, International journal of urology : official journal of the Japanese Urological Association.

The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy.

J. Crook, J. Borg, Clement Ma, 2010, Brachytherapy.

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients.

G. Perry, J. Crook, S. Malone, 2000, International journal of radiation oncology, biology, physics.

Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.

J. Crook, B. Esche, N. Futter, 1996, Urology.

Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.

J. Crook, C. Le Péchoux, P. Piedbois, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue.

J. Crook, P. Piedbois, V. Benk, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Iridium-192 implantation for t1 and t2 epidermoid carcinomas of the mobile tongue: the creteil experience

J. Crook, W. Walop, V. Benk, 1989 .

Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation — The creteil experience

J. Crook, W. Walop, J. Mazeron, 1989 .

Treatment options for localized prostate cancer.

Nawaid Usmani, Mira Keyes, W James Morris, 2013, Canadian family physician Medecin de famille canadien.

Canadian prostate brachytherapy in 2012.

Nawaid Usmani, Tom Pickles, Mira Keyes, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Radiation therapy in the management of the primary penile tumor: an update

J. Crook, Clement Ma, L. Grimard, 2009, World Journal of Urology.

Penile brachytherapy: results for 49 patients.

G. Pond, J. Crook, J. Jezioranski, 2005, International journal of radiation oncology, biology, physics.

Interstitial brachytherapy for penile cancer: an alternative to amputation.

C. Morash, J. Crook, T. Panzarella, 2002, The Journal of urology.

Radiotherapy for localized prostate carcinoma

R. Bociek, G. Perry, J. Crook, 1997, Cancer.

Dosimetric methods in the optimization of radiotherapy for carcinoma of the uterine cervix.

J. Horiot, J. Crook, B. Esche, 1987, International journal of radiation oncology, biology, physics.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?

J. Crook, J. Hamm, F. Bachand, 2020, Brachytherapy.

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

J. Crook, R. Pearcey, G. Thomas, 1999, Cancer.

A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy.

G. Pond, J. Crook, J. Borg, 2010, International journal of radiation oncology, biology, physics.

Oral malignancies. Interstitial irradiation and protective prostheses.

J. Crook, B. Esche, J. Hardie, 1990, Oral health.

Skin dose in breast brachytherapy: Defining a robust metric.

J. Crook, M. Hilts, F. Bachand, 2015, Brachytherapy.

Definitive radiation treatment for early stage carcinoma of the soft palate and uvula: the indications for iridium 192 implantation.

J. Crook, J. Mazeron, G. Marinello, 1987, International journal of radiation oncology, biology, physics.

European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update.

J. Crook, R. Campi, P. Johnstone, 2023, European urology.

Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth.

J. Crook, C. Le Péchoux, P. Piedbois, 1993, Radiotherapy and Oncology.

Effect of dose rate on local control and necrosis in the reirradiation of faucial arch squamous cell carcinomas with interstitial iridium 192.

J. Crook, J. Mazeron, 1990, International journal of radiation oncology, biology, physics.

Brachytherapy of neck metastases.

J. Crook, R. Choo, B. Esche, 1993, The Journal of otolaryngology.

Iridium 192 implantation of squamous cell carcinomas of the oropharynx.

J. Crook, J. Mazeron, R. Peynègre, 1989, American journal of otolaryngology.

Combined external irradiation and interstitial implantation for T1 and T2 epidermoid carcinomas of base of tongue: the Creteil experience (1971-1981).

J. Crook, J. Mazeron, G. Marinello, 1988, International journal of radiation oncology, biology, physics.

Multimodality therapy in penile cancer: when and which treatments?

J. Crook, L. Pagliaro, 2008, World Journal of Urology.

Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.

M. Brundage, J. Crook, H. Lukka, 1998, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial.

J. Crook, J. López, Juanita Crook, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MP74-01 NADIR TESTOSTERONE ON ADT PREDICTS FOR TIME TO CASTRATE RESISTANT PROGRESSION: A SECONDARY ANALYSIS OF THE PR-7 INTERMITTENT VS CONTINUOUS ADT TRIAL.

K. Ding, J. Crook, L. Klotz, 2014 .

A critical analysis of the long-term impact of brachytherapy for prostate cancer: a review of the recent literature

David Bowes, J. Crook, D. Bowes, 2011, Current opinion in urology.

Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature.

L. Budäus, T. Wiegel, M. Bolla, 2012, European urology.

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.

I. Spadinger, M. Keyes, J. Crook, 2015, Brachytherapy.

Radiotherapy approaches for locally advanced penile cancer: neoadjuvant and adjuvant

J. Crook, 2017, Current opinion in urology.

Twenty‐four‐month postradiation prostate biopsies are strongly predictive of 7‐year disease‐free survival

G. Lockwood, L. Eapen, G. Perry, 2009, Cancer.

Recent Advances in the Management of Penile Cancer: A Contemporary Review of the Literature

J. Crook, P. Chung, S. Sridhar, 2021, Oncology and Therapy.

Assessing Contemporary Trends in Female Speakership within Urologic Oncology.

Kirsten L. Greene, S. Psutka, E. Plimack, 2020, Urology.

Radiation therapy for the management of penile cancer

J. Crook, M. L. Smith, O. Algan, 2016, Journal of Radiation Oncology.

Applications of Radiation Therapy in the Management of Penile Cancer

J. Crook, M. Biagioli, 2013 .

HDR Prostate Brachytherapy.

Deidre Batchelar, J. Crook, Juanita Crook, 2020, Seminars in radiation oncology.

Reference volume, milligram-hours and external irradiation for the Fletcher applicator.

J. Horiot, J. Crook, B. Esche, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chapter 57 – Penile Cancer

J. Crook, J. Mazeron, 2016 .

Dose to the dominant intraprostatic lesion using HDR vs. LDR monotherapy: A Phase II randomized trial.

J. Crook, M. Hilts, F. Bachand, 2019, Brachytherapy.

A randomized trial comparing seed displacement of coated seeds to regular loose seeds at 30 days postimplant.

M. Milette, J. Crook, R. Halperin, 2013, Brachytherapy.

A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.

C. Catton, M. Mclean, J. Crook, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Effects of urethrography on prostate position: considerations for radiotherapy treatment planning of prostate carcinoma.

S. Dahrouge, J. Crook, L. Gerig, 2000, International journal of radiation oncology, biology, physics.

The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.

G. Pond, I. Yeung, M. Mclean, 2007, Brachytherapy.

The first International Penile Advanced Cancer Trial (InPACT) opens in Canada! Why additional centers are needed.

J. Crook, P. Spiess, C. Pettaway, 2022, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis.

C. Catton, P. Warde, M. Brundage, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer.

G. Lockwood, L. Eapen, G. Perry, 2009, International journal of radiation oncology, biology, physics.

Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue.

J. Crook, W. Walop, J. Mazeron, 1990, International journal of radiation oncology, biology, physics.

Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.

C. Ménard, T. Rosewall, C. Catton, 2007, International journal of radiation oncology, biology, physics.

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists.

J. Crook, D. D'Souza, G. Rodrigues, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long‐Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate Brachytherapy

M. Keyes, J. Crook, M. McKenzie, 2018, The Journal of urology.

Options for Salvage of Radiation Failures for Prostate Cancer.

J. Crook, A. Tétreault-Laflamme, 2017, Seminars in radiation oncology.

Long-term versus short-term androgen deprivation combined with EBRT for unfavourable prostate cancer.

J. Crook, 2022, The Lancet. Oncology.

Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer.

G. Lockwood, G. Perry, J. Crook, 2004, International journal of radiation oncology, biology, physics.

A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.

G. Lockwood, A. Nichol, T. Rosewall, 2010, International journal of radiation oncology, biology, physics.

Use of magnetic resonance imaging in low-dose-rate and high-dose-rate prostate brachytherapy from diagnosis to treatment assessment: Defining the knowledge gaps, technical challenges, and barriers to implementation.

C. Ménard, J. Crook, F. Mourtada, 2017, Brachytherapy.

An Internet-Based Means of Monitoring Quality of Life in Post-Prostate Radiation Treatment: A Prospective Cohort Study

J. Crook, R. Rajapakshe, C. Araujo, 2015, JMIR research protocols.

Alternative approaches and the future of treatment

I. Tannock, J. Trachtenberg, J. Crook, 2002 .

Editorial Comment.

J. Crook, 2019, The Journal of urology.

Commentary on "The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer".

J. Crook, 2015, Brachytherapy.

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients.

G. Perry, J. Crook, B. Esche, 1995, Urology.

Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium 192.

C. Abbou, D. Chopin, J. Crook, 1987, International journal of radiation oncology, biology, physics.

The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

G. Pond, J. Crook, E. Saibishkumar, 2009, Brachytherapy.

Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.

C. Catton, É. Vigneault, J. Crook, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG Oncology/xxxx).

D. Beyer, H. Sandler, É. Vigneault, 2021, International journal of radiation oncology, biology, physics.

Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

Joseph L. Chin, Celestia S. Higano, Fred Saad, 2013 .

Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.

J. Crook, N. Fleshner, M. Jewett, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term oncologic outcomes of radical prostatectomy compared with brachytherapy-based approaches for intermediate- and high-risk prostate cancer.

J. Crook, 2015, Brachytherapy.

The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy.

G. Pond, M. Mclean, J. Crook, 2002, Brachytherapy.

Prostate cancer: Elective pelvic nodal radiotherapy: is the jury still out?

J. Crook, 2016, Nature reviews. Urology.

Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant.

J. Crook, J. Simon, J. Mazeron, 1991, International journal of radiation oncology, biology, physics.

Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.

J. Crook, N. Fleshner, S. Fung, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optimal Radiotherapy for Unfavorable-risk Prostate Cancer.

J. Crook, 2017, European Urology.

Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion.

M. Milette, J. Crook, M. Hilts, 2014, Brachytherapy.

Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.

I. Yeung, J. Crook, E. Saibishkumar, 2008, Brachytherapy.

The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future.

J. Crook, Ana Fernandez-Ots, 2013, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study.

I. Hsu, L. Potters, M. Zelefsky, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy.

Jette Borg, J. Crook, J. Borg, 2010, International journal of radiation oncology, biology, physics.

A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery.

J. Crook, R. Halperin, A. Tétreault-Laflamme, 2018, Brachytherapy.

Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.

L. Potters, M. Zelefsky, W. Butler, 2021, Brachytherapy.

10-year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients.

Jette Borg, Andrew Evans, A. Evans, 2011, International journal of radiation oncology, biology, physics.

Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation.

C. Catton, I. Yeung, M. Mclean, 2002, International journal of radiation oncology, biology, physics.

External validation of the pretreatment nomogram to predict acute urinary retention after (125)I prostate brachytherapy.

M. Mclean, J. Crook, E. Saibishkumar, 2012, Brachytherapy.

Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposal.

D. Taussky, J. Crook, N. Fleshner, 2006, The Canadian journal of urology.

Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.

C. Catton, P. Warde, A. Berlin, 2019, Brachytherapy.

A biochemical definition of cure after brachytherapy for prostate cancer.

G. Merrick, W. J. Morris, J. Ciezki, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast Brachytherapy: Permanent Breast Seed Implants – How and Why?

J. Crook, J. Pignol, 2016 .

Outcomes after prostate brachytherapy are even better than predicted

J. Sylvester, P. Grimm, T. Pugh, 2012, Cancer.

Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy.

G. Pond, M. Mclean, J. Crook, 2006, Brachytherapy.

The role of intermittent androgen suppression in biochemically recurrent or newly diagnosed metastatic prostate cancer

J. Crook, 2013, Current opinion in supportive and palliative care.

Dose-volume analysis and the prevention of radiation sequelae in cervical cancer.

J. Horiot, J. Crook, B. Esche, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy.

M. Mclean, J. Crook, J. Borg, 2010, International journal of radiation oncology, biology, physics.

A reliable skin toxicity predictor in permanent breast seed implant brachytherapy.

J. Crook, M. Hilts, D. Batchelar, 2020, Brachytherapy.

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

M. Zelefsky, M. Keyes, É. Vigneault, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique.

M. Keyes, J. Crook, D. Batchelar, 2020, Brachytherapy.

Lessons Learned in Converting from LDR to HDR Penile Brachytherapy

M. Keyes, J. Crook, D. Batchelar, 2016 .

Management of Lymph Node-positive Penile Cancer: A Systematic Review.

J. Crook, R. Campi, P. Johnstone, 2023, European urology.

Optimal Equations for Describing the Relationship Between Prostate Volume, Number of Sources, and Total Activity in Permanent Prostate Brachytherapy

J. Sylvester, W. Butler, G. Merrick, 2009, American journal of clinical oncology.

Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.

Deidre Batchelar, Cynthia Araujo, David Bowes, 2013, Brachytherapy.

3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.

J. Crook, M. Pintilie, J. Jezioranski, 2011, International journal of radiation oncology, biology, physics.

The prostate cancer risk stratification project: database construction and risk stratification outcome analysis.

C. Catton, P. Warde, M. Brundage, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Cryosurgery Versus Primary Androgen Deprivation Therapy for Locally Recurrent Prostate Cancer After Primary Radiotherapy: A Propensity-Matched Survival Analysis

J. Chin, D. Dearnaley, K. Ding, 2020, Cureus.

MP-21.03: Penile brachytherapy: results for 60 patients

G. Pond, J. Crook, B. Esche, 2007 .

Penile brachytherapy: Results for 60 patients

G. Pond, J. Crook, B. Esche, 2007 .

Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decision.

J. Crook, P. Bilbao, A. Gomez-Iturriaga, 2017, Brachytherapy.

Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged

G. Lockwood, J. Crook, J. Borg, 2010, Urology.

Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy.

Ivan Yeung, Masoom A Haider, Pamela Catton, 2002, Brachytherapy.

Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.

H. Sandler, M. Kuettel, J. Crook, 2010, International journal of radiation oncology, biology, physics.

Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography.

G. Pond, I. Yeung, J. Crook, 2006, International journal of radiation oncology, biology, physics.

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.

D. Beyer, C. Catton, H. Sandler, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

517 oral QOL / OUTCOMES OF AN INTERNATIONAL PHASE 3 TRIAL OF INTERMITTENT V CONTINUOUS HORMONE THERAPY FOR RELAPSED PROSTATE CA

D. Dearnaley, G. Duncan, K. Ding, 2011 .

Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.

M. Haider, G. Lockwood, D. Taussky, 2004, Brachytherapy.

Morbidity after brachytherapy for prostate adenocarcinoma.

J. Crook, 2004, Mayo Clinic proceedings.

MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.

Ivan Yeung, G. Lockwood, I. Yeung, 2004, Brachytherapy.

The role of brachytherapy in the definitive management of prostate cancer.

J Crook, J. Crook, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

MRI-defined treatment margins, urinary toxicity, and PSA response in LDR prostate brachytherapy.

J. Crook, C. Araujo, J. Rose, 2022, Brachytherapy.

Radiation oncology and medical physicists quality assurance in British Columbia Cancer Agency Provincial Prostate Brachytherapy Program.

Howard Pai, William James Morris, Ingrid Spadinger, 2013, Brachytherapy.

Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy.

A. Evans, C. Catton, A. Finelli, 2012, Urology.

Intracavitary irradiation of carcinomas of the uterus and cervix: the Créteil method.

J. Crook, G. Marinello, B. Pierquin, 1988, International Journal of Radiation Oncology, Biology, Physics.

Iodine 125 Brachytherapy for Favorable Risk Prostate Cancer: Results for 509 Patients. When Can We Start to Trust PSA After Brachytherapy?

G. Lockwood, I. Yeung, M. Mclean, 2005 .

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

J. Crook, K. Gulenchyn, A. McEwan, 1993, International journal of radiation oncology, biology, physics.

Iodine versus palladium for prostate brachytherapy: the controversy continues.

J. Crook, 2004, Cancer journal.

Comparison of Health-related Quality of Life 5 Years after Brachytherapy (BT) or Radical Prostatectomy (RP): The SPIRIT (Surgical Prostatectomy vs. Interstitial Radiotherapy Intervention Trial) Cohort (ACOSOG Z0070)

J. Crook, N. Fleshner, S. Fung, 2010 .

Comparison of Health-Related Quality of Life 5 Years after Treatment for Men Who Either Chose or Were Randomized to Radical Prostatectomy or Brachytherapy after a SPIRIT (ACOSOG Z0070) Trial Education Session

J. Crook, N. Fleshner, M. Jewett, 2010 .

The Use of Image Guidance in Prostate Brachytherapy

C. Ménard, J. Crook, 2008 .

Target volume definition for post prostatectomy radiotherapy: Do the consensus guidelines correctly define the inferior border of the CTV?

J. Crook, R. Rajapakshe, M. Schmid, 2016, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Testing control of radiation-induced diarrhea with a psyllium bulking agent: a pilot study.

J. Crook, Brian Thompson, D. Stacey, 2000, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.

Prediction of outcome

J. Crook, I. Schultz, 2004 .

Posttreatment Complications of Early‐Stage Prostate Cancer Patients: Brachytherapy Versus Three‐Dimensional Conformal Radiation Therapy

Caitlin Gillan, Charles Catton, Gregory Pond, 2005, Cancer journal.

Capturing tumour stage in a cancer information database.

J Crook, J. Crook, W K Evans, 1998, Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC.

The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy.

K. Ding, C. Higano, J. Crook, 2020, European urology.

Outcomes after PD-103 versus I-125 for Low Dose Rate Prostate Brachytherapy Monotherapy: An International, Multi-Institutional Study.

R. Stock, M. Keyes, J. Crook, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Development of a 3D ultrasound guidance system for permanent breast seed implantation

Aaron Fenster, Justin Michael, Daniel Morton, 2018, Medical physics.